Clinical outcomes and safety of intravenous polymyxin B-based treatment in critically ill patients with carbapenem-resistant Acinetobacter baumannii nosocomial pneumonia
Luyao Qiao(Nanchang University), Yun Long(Chinese Academy of Medical Sciences & Peking Union Medical College), Tingting Xu(Tongji University), Qianlin Wang(Beijing University of Chemical Technology), Xin Liu(Memorial Sloan Kettering Cancer Center), Yang Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Jiaxin Yu(Chinese Academy of Medical Sciences & Peking Union Medical College), Wu Jiayu(Chinese Academy of Medical Sciences & Peking Union Medical College), Wei Zuo(Chinese Academy of Medical Sciences & Peking Union Medical College), Bo Zhang(Guilin Medical University), Jian‐Dong Jiang(Ningbo University)
Cited by 11
Related Papers
ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent
|Cancer Cell|2005|368
Chlorogenic acid effectively treats cancers through induction of cancer cell differentiation
|Theranostics|2019|185
Loss of Epigenetic Control of <i>Synuclein-γ</i> Gene as a Molecular Indicator of Metastasis in a Wide Range of Human Cancers
|Cancer Research|2005|179
Extracellular Signal-Regulated Kinase–Dependent Stabilization of Hepatic Low-Density Lipoprotein Receptor mRNA by Herbal Medicine Berberine
|Arteriosclerosis Thrombosis and Vascular Biology|2005|171